Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
Tickers
ACAD
ALBO
BIIB
RCKT
Tags
General
ACAD
News
From
Benzinga
Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today
December 27, 2021
Tickers
BIIB
Tags
News
Market News
Earnings
From
Benzinga
3 Unstoppable Stocks to Buy for 2022
December 23, 2021
Tickers
ADBE
BIIB
COST
LLY
Tags
LLY
Market News
COST
From
Motley Fool
Eisai shares sink after Japan regulators seek more data for review of Alzheimer’s drug
December 22, 2021
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
December 22, 2021
Tickers
ABBV
ABEV
ACB
ACEL
Tags
BGNE
AMGN
Today's Market
From
InvestorPlace
Expert Ratings For Biogen
December 22, 2021
Tickers
BIIB
Tags
Benzinga
BIIB
BZI/AAR
From
Benzinga
10 Biggest Price Target Changes For Wednesday
December 22, 2021
Tickers
ADGI
AGCO
ALXO
BIIB
Tags
ADGI
Analyst Ratings
Market News
From
Benzinga
Got $1,000? These 3 Stocks Are Still Absurdly Cheap
December 22, 2021
Tickers
ABBV
BIIB
EPD
VTRS
Tags
EPD
Market News
BIIB
From
Motley Fool
Analyst Ratings For Biogen
December 21, 2021
Tickers
BIIB
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Biogen’s decision to halve price of Alzheimer’s drug is ‘a day late and a dollar short,’ says Raymond James
December 20, 2021
Tickers
BIIB
LLY
SPX
Tags
SPX
CH:ROG
LLY
From
MarketWatch
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
Tags
General
News
Briefs
From
Benzinga
10 Biggest Price Target Changes For Monday
December 20, 2021
Tickers
ANTM
BIIB
CALT
CHD
Tags
Price Target Changes
JAZZ
ANTM
From
Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
Tickers
BIIB
Tags
Trading Ideas
Benzinga
Market News
From
Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
Tickers
ALVR
ARGX
BIIB
BNTX
Tags
GNFT
General
ALVR
From
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Alzheimer's disease
Biotech
BIIB
From
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Tickers
ASRT
ATRS
BIIB
CALT
Tags
XFOR
SABS
IPOs
From
Benzinga
More Specificity is What the Doctor Ordered
December 14, 2021
Tickers
ABOS
BIIB
LLY
Tags
ProMIS Neurosciences
Market News
ABOS
From
Benzinga
‘Grandma and grandpa aren’t going to figure this one out.’ Prescription-drug savings vanish in the Medicare shuffle
December 10, 2021
Tickers
ANTM
BIIB
CNC
CVS
Tags
CVS
HUM
BIIB
From
MarketWatch
Amid Shaky Launch Of Aduhelm, Biogen Mulls Substantial Layoffs: STAT News Report
December 10, 2021
Tickers
BIIB
Tags
BIIB
Health Care
General
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Tickers
ABBV
ALL
ALSN
AMGN
Tags
CVI
PFE
MEDS
From
Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Tickers
ACET
AMAM
AMRX
BIIB
Tags
VALN
NBIX
TXMD
From
Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
Tickers
ABBV
AMGN
BIIB
HOTH
Tags
AMGN
Hoth Therapeutics
Benzinga
From
Benzinga
Where Biogen Stands With Analysts
December 06, 2021
Tickers
BIIB
Tags
BIIB
Benzinga
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Tickers
AAL
AAPL
ACEL
AMGN
Tags
AMGN
MAG
CTOS
From
Benzinga
Should You Blame Biogen for Medicare Part B Premium Hikes?
December 03, 2021
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
Tickers
BIIB
SAGE
Tags
Movers
Briefs
News
From
Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Tickers
ADTX
ATNF
BIIB
BTAI
Tags
SNY
IMNM
General
From
Benzinga
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
Tickers
BIIB
VTRS
Tags
Benzinga
multiple sclerosis
Market News
From
Benzinga
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
November 28, 2021
Tickers
BIIB
RHHBY
Tags
Market News
RHHBY
Recent Press Releases
From
Motley Fool
2 Moonshot Biotechs with 10x Potential
November 22, 2021
Tickers
AMC
BIIB
LGVN
OXBOF
Tags
OXBOF
AMC
Market Insight, Financial Articles
From
InvestorPlace
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.